CHRS – coherus biosciences, inc. (US:NASDAQ)

News

Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock
Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock
Coherus Oncology, Inc. Announces Proposed Public Offering of Common Stock
Coherus Oncology (NASDAQ:CHRS) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating on the stock.
Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com